United States · FDA National Drug Code directory

BUDDATE REGES INTENSIVE TREATMENT

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 71173-3000_44ced40a-d974-eb5b-e063-6394a90a4ce6
Product NDC: 71173-3000
Form: CREAM
Composition / generic term: Butylene Glycol, Hydrogenated Coconut Oil, Butyrospermum Parkii (Shea) Butter, Palmitoyl Tripeptide-1, Palmitoyl Tetrapeptide-7
Labeler: BUDDATE Co Ltd
Marketing category: UNAPPROVED DRUG OTHER
Marketing start / end (source format): 20170101
Source listing expiry: 20261231

Source-listed ingredients

PALMITOYL TETRAPEPTIDE-7 — .000006 g/100mL
SHEA BUTTER — 3 g/100mL
PALMITOYL TRIPEPTIDE-1 — .000006 g/100mL
BUTYLENE GLYCOL — 5.57 g/100mL
HYDROGENATED COCONUT OIL — 4 g/100mL

These values do not establish equivalence or a dose recommendation.

Packages

70 mL in 1 TUBE (71173-3000-1) · 71173-3000-1

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →